Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer have?
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer has 2,266 citations in the OpenAlex counts ScholarIQ stores.
When was Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer published?
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer has 2017 year in the ScholarIQ index.
What is the open-access status of Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer?
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer?
The DOI for Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer is on the source record.
What is the PMID of Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer?
The PMID for Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer is on the source record.
What is the OpenAlex record for Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer?
The OpenAlex for Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer is on the source record.